AC
BOUT icon

AlphaCore Capital’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

AlphaCore Capital’s Portfolio BOUT Stock Details BOUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-230
Closed -$8.38K – 1249
2025
Q4 		$8.38K Buy
+230
New +$8.62K ﹤0.01% 1327

Other funds holding BOUT

CWM
Comprehensive Wealth Management Lynnwood, Washington $198M AUM 11.59% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $152M AUM 20.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MMCM
Murphy & Mullick Capital Management Smithtown, New York $135M AUM 29.14% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

AlphaCore Capital's BOUT Position: Q1 2026 in Review

AlphaCore Capital sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q1 2026, closing a stake of 230 shares — an estimated $8.38K sold.

AlphaCore Capital first reported a position in BOUT in Q4 2025 and held it in 1 quarter. The position peaked at $8.38K in Q4 2025. 14 funds tracked by Wall St. Rank hold BOUT as of Q1 2026.

  • AlphaCore Capital reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q1 2026 after selling out during the quarter.
  • AlphaCore Capital sold 230 CapForce IBD Breakout Opportunities ETF shares in Q1 2026, an estimated $8.38K.
  • AlphaCore Capital first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2025 and held it in 1 quarter.
  • AlphaCore Capital's CapForce IBD Breakout Opportunities ETF position peaked at $8.38K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.